0.9029
Talphera Inc stock is traded at $0.9029, with a volume of 93,792.
It is up +1.39% in the last 24 hours and up +25.00% over the past month.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.
See More
Previous Close:
$0.8905
Open:
$0.876
24h Volume:
93,792
Relative Volume:
0.49
Market Cap:
$46.86M
Revenue:
$28,000
Net Income/Loss:
$-14.36M
P/E Ratio:
-2.4873
EPS:
-0.363
Net Cash Flow:
$-11.36M
1W Performance:
+18.09%
1M Performance:
+25.00%
6M Performance:
-28.91%
1Y Performance:
+65.67%
Talphera Inc Stock (TLPH) Company Profile
Compare TLPH vs TAK, ZTS, TEVA, HLN, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
TLPH
Talphera Inc
|
0.9029 | 46.22M | 28,000 | -14.36M | -11.36M | -0.363 |
|
TAK
Takeda Pharmaceutical Co Adr
|
16.55 | 52.32B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
112.54 | 47.38B | 9.47B | 2.67B | 2.28B | 6.0218 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
35.86 | 41.16B | 17.53B | 1.58B | 444.18M | 1.3457 |
|
HLN
Haleon Plc Adr
|
9.17 | 41.02B | 14.54B | 2.22B | 2.58B | 0.4871 |
|
UTHR
United Therapeutics Corp
|
572.20 | 24.67B | 3.18B | 1.33B | 1.04B | 27.90 |
Talphera Inc Stock (TLPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-28-25 | Initiated | Rodman & Renshaw | Buy |
| Jul-20-20 | Downgrade | Credit Suisse | Neutral → Underperform |
| Nov-11-19 | Downgrade | Credit Suisse | Outperform → Neutral |
| Aug-05-19 | Resumed | Credit Suisse | Outperform |
| Jul-10-19 | Resumed | Credit Suisse | Outperform |
| Apr-24-19 | Resumed | B. Riley FBR | Buy |
| Feb-15-19 | Initiated | Credit Suisse | Outperform |
| Oct-23-18 | Initiated | B. Riley FBR | Buy |
| Oct-13-17 | Downgrade | Jefferies | Buy → Hold |
| Oct-13-17 | Reiterated | RBC Capital Mkts | Outperform |
| Jul-14-17 | Resumed | Jefferies | Buy |
| Sep-15-16 | Reiterated | ROTH Capital | Buy |
| Aug-05-16 | Downgrade | Stifel | Buy → Hold |
| Oct-30-15 | Upgrade | Jefferies | Hold → Buy |
| Oct-05-15 | Reiterated | ROTH Capital | Buy |
| Sep-02-15 | Initiated | H.C. Wainwright | Buy |
| Jul-10-15 | Resumed | ROTH Capital | Buy |
| May-06-15 | Reiterated | Mizuho | Neutral |
| May-05-15 | Reiterated | RBC Capital Mkts | Outperform |
| Mar-10-15 | Reiterated | RBC Capital Mkts | Outperform |
| Mar-09-15 | Downgrade | Mizuho | Buy → Neutral |
View All
Talphera Inc Stock (TLPH) Latest News
WestPark Capital initiates coverage of Talphera (TLPH) with buy recommendation - MSN
TLPH Stock: WestPark Capital Initiates Buy Rating, May 2026 - Meyka
TLPH Initiated Coverage by WestPark Capital -- Rating Set to Buy - GuruFocus
Talphera (NASDAQ: TLPH) seeks approval for equity and ESPP plan changes - Stock Titan
Talphera files prospectus for resale of up to 30.9M shares by selling stockholders - MSN
AcelRx Pharmaceuticals Q1 2025 Earnings Preview - MSN
TLPH (Talphera Inc.) beats Q4 2025 EPS estimates, but shares fall 2.35 percent amid absent revenue comparison metrics.Market Hype Signals - Cổng thông tin điện tử tỉnh Lào Cai
What could move Talphera (TLPH) stock next (Near Lows) 2026-04-20Collaborative Trading Signals - Xã Thanh Hà
Talphera (TLPH) Stock Equalweight (Momentum Building) 2026-04-20ATR Levels - Cổng thông tin điện tử tỉnh Lào Cai
Book value per share of Talphera, Inc. – SWB:R5XA - TradingView — Track All Markets
Talphera, Inc. (NASDAQ:TLPH) Q1 2025 Earnings Call Transcript - MSN
TLPH SEC FilingsTalphera Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Market Review: Will Talphera Inc stock hit new highs in YEAR2026 Technical Overview & Expert Approved Trade Ideas - baoquankhu1.vn
Geopolitics Watch: Is Talphera Incs growth already priced in2026 Buyback Activity & Daily Technical Forecast Reports - baoquankhu1.vn
Is Talphera (TLPH) Stock Gaining Momentum | Price at $0.83, Up 4.81%Insider Selling - Newser
Ideas Watch: Is Talphera Inc stock a falling knife or bargain buy2026 Pullbacks & Free Daily Entry Point Trade Alerts - baoquankhu1.vn
Risk Recap: Will Talphera Inc stock hit new highs in YEAR - baoquankhu1.vn
TALPHERA (TLPH) CEO uses 9,938 shares to cover RSU tax withholding - Stock Titan
Talphera (TLPH) CFO surrenders shares to cover RSU tax bill - Stock Titan
TALPHERA, INC. (TLPH) CMO surrenders 2,118 shares for RSU taxes - Stock Titan
[Form 4] TALPHERA, INC. Insider Trading Activity - Stock Titan
[EFFECT] TALPHERA, INC. SEC Filing - Stock Titan
Trend Recap: Does Talphera Inc stock reflect fundamentalsMarket Growth Summary & Free Technical Confirmation Trade Alerts - baoquankhu1.vn
Talphera (NASDAQ: TLPH) registers resale of 639,931 shares and 6.4M warrant shares - Stock Titan
Will Talphera Inc benefit from current market trends2026 Closing Moves & Daily Oversold Bounce Ideas - baoquankhu1.vn
Maxim Group Maintains Talphera(TLPH.US) With Buy Rating, Maintains Target Price $3 - 富途牛牛
Rate Cut: Why is Talphera Inc stock going down2026 Institutional Moves & Weekly Watchlist of Top Performers - baoquankhu1.vn
TLPH Should I Buy - Intellectia AI
Fed Meeting: Is Talphera Inc stock overvalued or fairly pricedQuarterly Portfolio Summary & Trade Opportunity Analysis Reports - baoquankhu1.vn
Dow Update: Whats the profit margin of Talphera IncGlobal Markets & Technical Pattern Based Buy Signals - baoquankhu1.vn
Aug EndMonth: Is Talphera Inc a top pick in the sectorMarket Sentiment Review & Verified Short-Term Trading Plans - baoquankhu1.vn
Angotti buys Talphera (TLPH) shares worth $124,999 By Investing.com - Investing.com Australia
Angotti buys Talphera (TLPH) shares worth $124,999 - Investing.com
Talphera (TLPH) CEO boosts stake with 213,310-share open-market buy - Stock Titan
Talphera Announces Two Abstracts Accepted for Presentation at AKI & CRRT 2026 - Bitget
Talphera (TLPH) registers resale of up to 7.04M shares from private placement - stocktitan.net
Talphera (TLPH) Reports Progress in Nafamostat Study and Financi - GuruFocus
Talphera: Q4 Earnings Snapshot - theheraldreview.com
Talphera, Inc. (Formerly AcelRx) 2025 Annual Report: Business Overview, Key Risks, and Regulatory Challenges in Specialty Pharmaceuticals - Minichart
Talphera Q4 2025 & Investor Day Earnings Call Transcript - MarketBeat
Talphera Inc Stock (TLPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):